Los Angeles Capital Management’s Phibro Animal Health PAHC Stock Holding History

Los Angeles Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11M	Sell	67,083 -24,984	-27%	-$1.05M	0.01%	582
2026 Q1	$5.09M	Buy	92,067 +53,623	+139%	+$2.55M	0.02%	334
2025 Q4	$1.61M	Sell	38,444 -23,715	-38%	-$963K	0.01%	496
2025 Q3	$2.51M	Sell	62,159 -15,238	-20%	-$503K	0.01%	451
2025 Q2	$1.98M	Buy	77,397 +55,305	+250%	+$1.21M	0.01%	461
2025 Q1	$472K	Sell	22,092 -1,950	-8%	-$43.6K	﹤0.01%	760
2024 Q4	$505K	Buy	24,042 +503	+2%	+$11.6K	﹤0.01%	811
2024 Q3	$530K	Sell	23,539 -2,600	-10%	-$50.2K	﹤0.01%	848
2024 Q2	$438K	Sell	26,139 -3,000	-10%	-$48.2K	﹤0.01%	899
2024 Q1	$377K	Buy	+29,139	New	+$349K	﹤0.01%	947
2019 Q2	–	Sell	-44,055	Closed	-$1.45M	–	1398
2019 Q1	$1.45M	Sell	44,055 -8,920	-17%	-$278K	0.01%	739
2018 Q4	$1.7M	Sell	52,975 -475	-0.9%	-$17.9K	0.01%	598
2018 Q3	$2.29M	Hold	53,450	–	–	0.01%	634
2018 Q2	$2.46M	Hold	53,450	–	–	0.01%	638
2018 Q1	$2.12M	Sell	53,450 -11,975	-18%	-$443K	0.01%	625
2017 Q4	$2.19M	Buy	65,425 +29,241	+81%	+$1.04M	0.01%	646
2017 Q3	$1.34M	Buy	36,184 +20,890	+137%	+$784K	0.01%	727
2017 Q2	$567K	Buy	15,294 +3,770	+33%	+$123K	﹤0.01%	907
2017 Q1	$324K	Buy	+11,524	New	+$325K	﹤0.01%	997

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Los Angeles Capital Management's PAHC Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Phibro Animal Health (PAHC) stake by 27% in Q2 2026, selling an estimated $1.05M and leaving 67,083 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #582.

Los Angeles Capital Management first reported a position in PAHC in Q1 2017 and has held it in 19 quarters since. The position peaked at $5.09M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Los Angeles Capital Management held 67,083 shares of Phibro Animal Health worth $2.11M as of Q2 2026.
Los Angeles Capital Management sold 24,984 Phibro Animal Health shares in Q2 2026, an estimated $1.05M.
Phibro Animal Health made up 0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #582 holding.
Los Angeles Capital Management first reported a position in Phibro Animal Health in Q1 2017 and has held it in 19 quarters since.
Los Angeles Capital Management's Phibro Animal Health position peaked at $5.09M in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.